Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 6/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.38 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.38 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.38 |
| ▸ | ASIC3 | Q9UHC3 | 4/20 | 0.37 |
| ▸ | HNF4A | P41235 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1290051 | 0.72 | MAOA (0.41) | MAPTRAB9ACA1CA9MEN1 | |
| SCHEMBL29383148 | 0.72 | MAOA (0.41) | MAPTRAB9ACA1CA9MEN1 | |
| SCHEMBL19386145 | 0.70 | MAOA (0.39) | MAPTRAB9ACA1CA9MEN1 | |
| SCHEMBL29787236 | 0.70 | APP (0.52) | GRM5APPMAPTIP6K1IP6K3 | |
| SCHEMBL19683509 | 0.70 | MAOA (0.42) | MAPTRAB9ACA1CA9MEN1 | |
| SCHEMBL10300103 | 0.68 | GRM5 (0.57) | GRM5APPMAPTASIC3HNF4A | |
| SCHEMBL15071003 | 0.68 | APP (0.50) | GRM5APPMAPTIP6K1IP6K3 | |
| SCHEMBL13330692 | 0.68 | IP6K1 (0.46) | GRM5APPMAPTIP6K1IP6K3 | |
| SCHEMBL19683502 | 0.68 | MAOA (0.41) | CA1CA9MEN1KMT2A | |
| SCHEMBL2114741 | 0.67 | APP (0.92) | GRM5APPMAPTHNF4ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079872-B2 | Phenanthro[9, 10-B]furans for electronic applications | BASF SE (DE) | 2015-07-14 | — | — | US | disclosed |
| US-9079872-B2 | Phenanthro[9, 10-B]furans for electronic applications | BASF SE (DE) | 2015-07-14 | — | — | US | disclosed |
| EP-2625171-B1 | PHENANTHRO[9,10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-07-30 | — | — | EP | disclosed |
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-04-19 | — | — | US | disclosed |
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | P2RY10, P2RY11, P2RY12 | GRM5 2984/4885APP 300/4885MAPT 2560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.